Bullish market stimulation boosts Hong Kong healthcare stocks, causing Lai Kai Pharmaceuticals to surge over 18%.

①What bullish news about pharmaceutical stocks has recently been announced in the market? ②How do institutions view the subsequent performance of pharmaceutical stocks?

cls.cnNov 19 22:50 ET

Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation

①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.

cls.cnNov 19 08:17 ET

3SBio's Mandi Shines in 2024 Double 11 Sales

TipRanksNov 14 06:10 ET

3SBio CFO Boosts Shareholding, Confident in Future

TipRanksNov 14 06:10 ET

The chief financial officer of 3sbio, He Xiang, increased his shareholding by a total of 3 million shares.

Gelonghui, November 14th | 3sbio (01530.HK) announced that it recently received a report from the company's chief financial officer, Mr. He Xiang, stating that from January 1, 2024, to the date of this announcement, he has cumulatively increased his shareholding in the company by purchasing a total of 3 million ordinary shares through centralized bidding at an average price of approximately HKD 5.99 per share, accounting for about 0.12% of the total issued shares. Mr. He indicated to the board of directors that he believes the shares are undervalued in the long term and, based on his long-term confidence in the company's business and prospects, he will consider increasing his shareholding further depending on market conditions and subject to applicable laws and regulatory provisions.

Gelonghui FinanceNov 14 06:00 ET

3sbio (01530.HK): "On singles' day sales, Mandi topped the charts on multiple platforms."

On November 14th, 3sbio (01530.HK) announced that its subsidiary Zhejiang Sanse Mandy Pharmaceutical Co., Ltd. during the "singles' day sales" campaign in 2024: the main brand Mandy ranked first in OTC brand total payment commodity trade volume (GMV) on the Tmall platform; the core product Mandy hair foam agent of JD Pharmaceutical won the first place in the OTC single product payment GMV list; the main brand Mandy on Douyin Mall won the first place in the medicine and health brand payment GMV list.

Gelonghui FinanceNov 14 05:57 ET